Navigation Links
New Sub-Analysis of RE-LY Trial Examines Pradaxa in Patients with Atrial Fibrillation Undergoing Cardioversion
Date:1/5/2011

inhibitors.

ADVERSE REACTIONS

In the pivotal trial comparing PRADAXA to warfarin, the most frequent adverse reactions leading to discontinuation of PRADAXA were bleeding and gastrointestinal events. PRADAXA 150 mg resulted in a higher rate of major gastrointestinal (GI) bleeds and any GI bleeds compared to warfarin. In patients greater than or equal to 75 years of age, the risk of major bleeding may be greater with PRADAXA than with warfarin. Patients on PRADAXA 150 mg had an increased incidence of GI adverse reactions.  These were commonly dyspepsia (including abdominal pain, upper abdominal pain, abdominal discomfort, and epigastric discomfort) and gastritis-like symptoms (including GERD, esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, and GI ulcer).  Drug hypersensitivity reactions were reported in <0.1% of patients receiving PRADAXA.

Other Measures Evaluated

The risk of myocardial infarction was numerically greater in patients who received PRADAXA 150 mg than in those who received warfarin.  

For full PRADAXA prescribing information, please visit www.pradaxa.com or contact Boehringer Ingelheim's Drug Information Unit at 1-800-542-6257.

About Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates in 50 countries and more than 41,500 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. New PLATO Sub-Analysis of CABG Patients Presented at ACC
2. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
3. Data Published in The Lancet Compare Dabigatran Etexilate to Dose-Adjusted Warfarin Across RE-LY® Trial Centers
4. New Analyses of Data From RE-LY Trial, Involving Oral Anticoagulant Pradaxa, to be Presented at American Heart Associations Scientific Sessions
5. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
8. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
9. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 2015  Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY ... commercialization of proprietary compounded drug therapies, today reported that ... 2014 financial results on Thursday, March 12, 2015.  The ... EDT (1:30 p.m. PDT) on the same day to ... activities.  The conference call and webcast will be open ...
(Date:3/4/2015)... Perrigo Company plc (NYSE: PRGO ; TASE) today ... Papa will present at the 2015 Barclays Global Healthcare ... the Loews Miami Beach Hotel in Miami, FL. ... http://perrigo.investorroom.com/events-webcasts . From its beginnings as a ... headquartered in Ireland , has grown to ...
(Date:3/4/2015)... 2015  ANI Pharmaceuticals, Inc. (NASDAQ: ANIP ) ... ROTH Conference at the Ritz-Carlton at Laguna Niguel, ... PT, Arthur S. Przybyl , President and CEO, will ... section of ANI,s website at www.anipharmaceuticals.com . Mr. Przybyl,s ... archived and available through the link through June 7, 2015. ...
Breaking Medicine Technology:Imprimis Pharmaceuticals to Host its Fourth Quarter and Fiscal Year 2014 Financial Report Conference Call and Webcast on March 12, 2015 at 4:30 p.m. EDT 2Imprimis Pharmaceuticals to Host its Fourth Quarter and Fiscal Year 2014 Financial Report Conference Call and Webcast on March 12, 2015 at 4:30 p.m. EDT 3Perrigo Company To Present At The 2015 Barclays Global Healthcare Conference 2ANI Pharmaceuticals To Present At 27th Annual ROTH Conference 2
... Scientific Corporation (NYSE: BSX ) will webcast its conference ... 30, 2009 on Tuesday, October 20, at 8:00 a.m. ET. ... and Chief Executive Officer, and Sam Leno, Executive Vice President ... replay of this call will be available at ...
... ... Services will pay the United States $1.375 million to resolve False ... the guise of a sham durable medical equipment (DME) provider, the ... its affiliate MediNet Corp. provided the kickbacks and assistance and, in ...
Cached Medicine Technology:Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results 2Harborside Healthcare to Pay U.S. $1.375 Million to Resolve Allegations of Kickbacks and Sham Durable Medical Services 2
(Date:3/4/2015)... Alliance Healthcare Foundation (AHF), a non-profit ... in need in San Diego and Imperial Counties, announced ... Mission Support Grants program with awards totaling $1 million. ... AHF’s Mission Support Grants program. Grant recipients were chosen ... and program committee, as well as the community as ...
(Date:3/4/2015)... The Global Liquefied Petroleum Gas ... and is estimated to grow to $288.7 billion ... 2014 to 2019. , Browse through the TOC ... analysis of industry trends, segments & forecasts., ... gas market is classified into source, application, and ...
(Date:3/4/2015)... RapidScale, a global cloud services innovator, is attending ... 16th-18th. They are hosting Booth #1010 on the expo ... engineering executives in attendance to provide demos and discuss ... include William Hiatt, CTO; Jeff Richards, Cloud Delivery Manager; ... Support Manager. , RapidScale is also hosting two ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 According to ... millions of people in the U.S. suffer from gastroesophageal ... Medications are commonly prescribed to control acid production, but ... procedures can overly correct the problem and lead to ... Opportunity, GERD occurs when the lower esophageal sphincter does ...
(Date:3/4/2015)... The Conrad N. Hilton Foundation has ... $6.9 million, which will help 151,000 people access safe, ... , The programs cover three years and the investment ... fixing water points in disrepair, addressing water quality ... maintain water points and ensuring safe water supplies for ...
Breaking Medicine News(10 mins):Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 2Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 3Health News:The Global Liquefied Petroleum Gas Market is Estimated to Reach $288.7 Billion by 2019 - A Report by MicroMarket Monitor 2Health News:The Global Liquefied Petroleum Gas Market is Estimated to Reach $288.7 Billion by 2019 - A Report by MicroMarket Monitor 3Health News:Rapidscale to Host First Cloudtalk Events at Channel Partners in Las Vegas 2Health News:Rapidscale to Host First Cloudtalk Events at Channel Partners in Las Vegas 3Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 2Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 2Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 4
... for their effects on fat development, researchers have discovered ... in mice without some of the side effects ... they pinpointed, known as harmine, was first isolated more ... ritual and medicinal preparations around the world, the team ...
... and neglect of young children in military families in Texas ... at Chapel Hill study shows, raising concerns about the impact ... the country. ,The study, published in the ... was designed by UNC School of Public Health researchers to ...
... imported fire ants (RIFAs), which have caused trouble in ... Virginia. Colonies of the tiny, highly aggressive insects have ... in recent years, have caught the attention of Virginia ... the increasing number of fire ant infestations. ...
... 800 poultry farms in the capital following an outbreak of ... Saturday. ,The deadly H5N1 bird flu ... two other farms the next day in Chak Shehzad, a ... Usmani. ,Several thousand chickens were killed by the ...
... 30 seconds, it rivals HIV and tuberculosis as the world's ... are under five years old. Now, just over 100 years ... Prize for finally proving that malaria is transmitted by mosquitoes, ... a significant breakthrough in the search for an effective vaccine. ...
... specific antigen (PSA) levels is the most significant predictor of ... published in the journal Cancer. ,The study ... (PSA Velocity) is more than 2 ng/ml/year, it is an ... ,According to the researchers, the new findings attain ...
Cached Medicine News:Health News:Fat Screen Delivers Plant-derived Chemical With Antidiabetic Effects 2Health News:Stress of Deployment Increases Risk of Child Abuse, Neglect in Military Families, UNC Study Shows 2Health News:Stress of Deployment Increases Risk of Child Abuse, Neglect in Military Families, UNC Study Shows 3Health News:Fire Ants are Emerging Nuisance for Virginians 2Health News:Fire Ants are Emerging Nuisance for Virginians 3Health News:Vaccine Hope for Malaria 2Health News:Scientists Identify the Most Significant Single Predictor of Aggressive Prostate Cancer 2
For use with Snap-In Snap-Out-II tip inserts. Available in five styles, the Snap-In Snap-Out-II Laparoscopic Instrument Handles offer the broadest range available....
Inquire...
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Medicine Products: